Literature DB >> 22526271

One- and two-step self-expandable metal stent placement for distal malignant biliary obstruction: a propensity analysis.

Tsuyoshi Hamada1, Yousuke Nakai, Hiroyuki Isayama, Osamu Togawa, Hirofumi Kogure, Kazumichi Kawakubo, Takeshi Tsujino, Naoki Sasahira, Kenji Hirano, Natsuyo Yamamoto, Yukiko Ito, Takashi Sasaki, Suguru Mizuno, Nobuo Toda, Minoru Tada, Kazuhiko Koike.   

Abstract

BACKGROUND: Although self-expandable metal stents (SEMS) are widely used for distal malignant biliary obstruction, one-step SEMS (direct placement without a prior plastic stent) and two-step SEMS (placement at second endoscopic retrograde cholangiopancreatography [ERCP] following plastic stent placement) have not been fully compared.
METHODS: In this multicenter retrospective study, patients were included who underwent first-time endoscopic SEMS placement between September 1994 and December 2010. We compared the one-step and two-step strategies using a propensity analysis.
RESULTS: In total, 370 patients were identified and one-step SEMS was performed in 59 patients. After adjustment using propensity scores, the median times to dysfunction were 116 and 219 days, respectively, for one-step and two-step SEMS (P = 0.058). Stent migration was more frequently observed in one-step SEMS as compared with two-step SEMS (25 vs. 11 %, P = 0.031). In one-step SEMS, the number of days of hospitalization associated with first-time SEMS placement was shorter compared with that in two-step SEMS (21 vs. 30 days, P = 0.001), and the total costs of SEMS-related interventions within 6 months were lower (6510 and 8100 USD, P = 0.004). The pathological diagnosis rates for pancreatic and biliary tract cancer at initial ERCP were 52 and 61 %. After failed diagnosis at initial ERCP, pathological diagnosis rates for pancreatic cancer were 32 versus 76 % (P = 0.005) by repeated ERCP versus endoscopic ultrasound (EUS)-guided fine-needle aspiration (FNA).
CONCLUSIONS: One-step SEMS was associated with increased stent migration, despite having potential cost-effectiveness. The additional yield of pathological diagnosis at repeated ERCP was low compared with that yielded by EUS-guided FNA.

Entities:  

Mesh:

Year:  2012        PMID: 22526271     DOI: 10.1007/s00535-012-0582-3

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  43 in total

1.  Endoscopic removal of malfunctioning biliary self-expandable metallic stents.

Authors:  Pietro Familiari; Milutin Bulajic; Massimiliano Mutignani; Linda S Lee; Gianluca Spera; Cristiano Spada; Andrea Tringali; Guido Costamagna
Journal:  Gastrointest Endosc       Date:  2005-12       Impact factor: 9.427

2.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

3.  The clinical utility of endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of pancreatic carcinoma.

Authors:  K J Chang; P Nguyen; R A Erickson; T E Durbin; K D Katz
Journal:  Gastrointest Endosc       Date:  1997-05       Impact factor: 9.427

4.  Efficacy and safety of the covered Wallstent in patients with distal malignant biliary obstruction.

Authors:  Yousuke Nakai; Hiroyuki Isayama; Yutaka Komatsu; Takeshi Tsujino; Nobuo Toda; Naoki Sasahira; Natsuyo Yamamoto; Kenji Hirano; Minoru Tada; Haruhiko Yoshida; Takao Kawabe; Masao Omata
Journal:  Gastrointest Endosc       Date:  2005-11       Impact factor: 9.427

5.  Covered self-expandable metal stents in pancreatic malignancy regardless of resectability: a new concept validated by a decision analysis.

Authors:  M Kahaleh; A Brock; M R Conaway; V M Shami; J M Dumonceau; P G Northup; J Tokar; T A Rich; R B Adams; P Yeaton
Journal:  Endoscopy       Date:  2007-03-15       Impact factor: 10.093

Review 6.  Comparison of endoscopic ultrasound and computed tomography for the preoperative evaluation of pancreatic cancer: a systematic review.

Authors:  John Dewitt; Benedict M Devereaux; Glen A Lehman; Stuart Sherman; Thomas F Imperiale
Journal:  Clin Gastroenterol Hepatol       Date:  2006-05-03       Impact factor: 11.382

7.  Combined EUS with FNA and ERCP for the evaluation of patients with obstructive jaundice from presumed pancreatic malignancy.

Authors:  William A Ross; Sanjeev M Wasan; Douglas B Evans; Robert A Wolff; Leonard V Trapani; Gregg A Staerkel; Thomas Prindiville; Jeffrey H Lee
Journal:  Gastrointest Endosc       Date:  2008-04-02       Impact factor: 9.427

8.  Management of distal malignant biliary obstruction with the ComVi stent, a new covered metallic stent.

Authors:  Hiroyuki Isayama; Takao Kawabe; Yousuke Nakai; Yukiko Ito; Osamu Togawa; Hirofumi Kogure; Yoko Yashima; Hiroshi Yagioka; Saburo Matsubara; Takashi Sasaki; Naoki Sasahira; Kenji Hirano; Takeshi Tsujino; Minoru Tada; Masao Omata
Journal:  Surg Endosc       Date:  2009-06-11       Impact factor: 4.584

9.  Simultaneous endoscopic ultrasound fine needle aspiration and endoscopic retrograde cholangio-pancreatography: Evaluation of safety.

Authors:  Ilaria Tarantino; Luca Barresi; Marta Di Pisa; Mario Traina
Journal:  World J Gastroenterol       Date:  2007-07-28       Impact factor: 5.742

10.  A prospective, randomized, controlled trial of metal stents for malignant obstruction of the common bile duct.

Authors:  K Knyrim; H J Wagner; J Pausch; N Vakil
Journal:  Endoscopy       Date:  1993-03       Impact factor: 10.093

View more
  2 in total

1.  Partially covered self-expandable metal stents versus polyethylene stents for malignant biliary obstruction: a cost-effectiveness analysis.

Authors:  Alan N Barkun; Viviane Adam; Myriam Martel; Khalid AlNaamani; Peter L Moses
Journal:  Can J Gastroenterol Hepatol       Date:  2015-06-30

2.  Comparison of endoscopic stenting for malignant biliary obstruction: A single-center study.

Authors:  Ryuichi Yamamoto; Masatomo Takahashi; Yasuyo Osafune; Katsuya Chinen; Shingo Kato; Sumiko Nagoshi; Koji Yakabi
Journal:  World J Gastrointest Endosc       Date:  2015-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.